Virbac Stock price

Equities

VIRP

FR0000031577

Pharmaceuticals

Real-time Euronext Paris 08:14:28 2024-03-28 am EDT 5-day change 1st Jan Change
340 EUR +0.44% Intraday chart for Virbac -0.87% -5.42%
Sales 2023 1.25B 1.35B Sales 2024 * 1.35B 1.46B Capitalization 2.83B 3.06B
Net income 2023 121M 131M Net income 2024 * 134M 145M EV / Sales 2023 2.43 x
Net cash position 2023 * 118M 127M Net cash position 2024 * 160M 172M EV / Sales 2024 * 1.98 x
P/E ratio 2023
25 x
P/E ratio 2024 *
21.4 x
Employees 5,459
Yield 2023 *
0.48%
Yield 2024 *
0.42%
Free-Float 49.58%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.31%
Current month+1.96%
1 month-0.44%
3 months-6.23%
6 months+39.01%
Current year-5.84%
More quotes
1 week
335.50
Extreme 335.5
352.00
1 month
316.50
Extreme 316.5
352.00
Current year
316.50
Extreme 316.5
364.50
1 year
232.50
Extreme 232.5
364.50
3 years
215.00
Extreme 215
448.50
5 years
132.20
Extreme 132.2
448.50
10 years
102.10
Extreme 102.1
448.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 05-12-31
Director of Finance/CFO 48 16-01-31
Chief Operating Officer - 23-06-30
Members of the board TitleAgeSince
Director/Board Member 65 10-12-31
Director/Board Member 64 03-12-31
Chairman 59 97-12-31
More insiders
Date Price Change Volume
24-03-28 340 +0.44% 124
24-03-27 338.5 -1.74% 1,707
24-03-26 344.5 -0.86% 1,868
24-03-25 347.5 +0.58% 4,331
24-03-22 345.5 +0.73% 3,798

Real-time Euronext Paris, March 28, 2024 at 04:15 am EDT

More quotes
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.8%), Europe (24.9%), Asia (17.5%), Latin America (16.2%), North America (13.3%), Pacific (9.7%), Africa and Middle East (2.6%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
338.5 EUR
Average target price
351.3 EUR
Spread / Average Target
+3.77%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Virbac - Euronext Paris